Physician profile
Sylvia Chen
NPI 1023131786
$2,452.14
in general payments reported to CMS, 2019-2025
31 companies · $239 in 2025
The $239 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $619 · 2022: $739 · 2023: $487 · 2024: $368 · 2025: $239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,094.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,094.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $345.75 | 2021-2025 | Nexplanon |
| Novo Nordisk INC | $338.57 | 2021-2025 | Wegovy |
| Mayne Pharma Commercial LLC | $203.66 | 2021-2025 | |
| Abbvie INC. | $193.28 | 2021-2022 | |
| Evofem Biosciences, INC. | $144.02 | 2021-2025 | Phexxi, Solosec, Phexx |
| Astellas Pharma US INC | $135.71 | 2023-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $126.78 | 2021-2025 | |
| Agile Therapeutics, INC. | $123.03 | 2021-2024 | Twirla |
| Myovant Sciences INC. | $83.18 | 2022 | |
| Exeltis, USA INC. | $69.37 | 2021-2024 | Slynd |
| Sumitomo Pharma America, INC. | $68.25 | 2023-2025 | Myfembree |
| Aspira Women'S Health INC | $61.76 | 2022-2024 | Ova1 |
| Pfizer INC. | $57.83 | 2022 | |
| Daiichi Sankyo INC. | $52.00 | 2021 | |
| Hologic Sales and Service, LLC | $49.01 | 2022-2023 | Aptima |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $44.49 | 2023-2025 | Zepbound, Mounjaro |
| Mylan Pharmaceuticals INC. | $37.79 | 2021 | |
| Boston Scientific Corporation | $37.49 | 2022-2024 | Wavewriter Alpha Prime 16 |
| Exact Sciences Corporation | $34.54 | 2023-2024 | Cologuard Collection Kit |
| Cepheid | $34.00 | 2025 | Genexpert |
| Amgen INC. | $24.71 | 2021 | |
| Therapeuticsmd, INC. | $23.44 | 2021 | |
| Millicent US INC | $22.62 | 2025 | Intrarosa, Femring |
| Avion Pharmaceuticals | $21.33 | 2022 | |
| Coloplast Corp | $21.01 | 2021 | |
| Ascend Therapeutics US, LLC | $19.31 | 2024 | |
| Ethicon US, LLC | $18.74 | 2024 | Vistaseal |
| Medtronic, INC. | $17.42 | 2021 | |
| Coopersurgical, INC. | $17.08 | 2023 | Paragard T 380a |
| Biotissue Holdings INC. | $14.05 | 2021 | |
| Medicem INC. | $11.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sylvia Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.